Image

Global Genetic Disorders Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Sep 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Pharmaceutical
  • Upcoming Report
  • Sep 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Genetic Disorders Market, By Indication (CF, DMD, LSD, PNH), Disease Type (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, DMD, Thalassemia, Huntington’s Disease, Rare Diseases, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Genetic Disorders Market Market Analysis and Insights of Genetic Disorders Market

Genetic disorders market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 13.73% in the above-mentioned forecast period.

Genetic disorders are basically the inherited disorders which is caused by a change, or mutation in DNA sequence and is passed onto the next-generation by gene transferring from one generation to the others. They can be life-threating and are progressive in nature with each disease carrying different symptoms and even are very rare and complicated and to treat and also require specialized treatments or therapeutics.

The factors such prevailing cases of genetic and chronic disease along with the increasing government initiatives in creating awareness regarding the genetic test and diagnosis are primarily responsible for driving the growth of the genetic disorders market. Additionally, significant volume and strength of pipeline drugs and therapies for genetic disorders and increasing prevalence of drugs being approved in the recent years along with various drugs entering their last or late-stage of development also heighten the overall growth of the market. However, the prevalence and attrition towards reduction of drugs in clinical trial for genetic disorders and high costs associated with the diagnosis and identification of genetic disorders are estimated to obstruct the market’s growth.

The increasing technological advancement and research and development funding are expected to generate profitable opportunities for the market. On the other hand, the complications related to social and ethical categories with the utilization of genetic testing have the potential to challenge for the market’s growth.

This genetic disorders market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research genetic disorders market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Genetic Disorders Market Scope and Market Size

Genetic disorders market is segmented on the basis of indication and disease type. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of indication, the market is segmented into CF, DMD, LSD and PNH.
  • On the basis of disease type, the genetic disorders market is segregated into Alzheimer’s disease, cancer, cystic fibrosis, sickle cell anemia, DMD, thalassemia, huntington’s disease, rare diseases and others.

Genetic Disorders Market Country Level Analysis

Genetic disorders market is analyzed and market size insights and trends are provided by indication and disease type as referenced above.

The countries covered in the genetic disorders market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genetic disorders market due to the availability of skilled professionals and sophisticated genetic testing equipment within the region. Asia-Pacific on the other hand, is anticipated to show a rapid and lucrative growth rate in the forecast period of 2021 to 2028 owing to rising healthcare expenditure and growing government initiatives pertaining to the development of healthcare infrastructure.

The country section of the genetic disorders market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Genetic Disorders Market Share Analysis

Genetic disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genetic disorders market.

The major players covered in the genetic disorders market report are Amicus Therapeutics, Inc., Alexion Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated; F. Hoffmann-La Roche Ltd; Abbott; Amgen Inc., ELITechGroup, GW Pharmaceuticals plc.,  Pfizer Inc, PerkinElmer Inc, AutoGenomics, Bio-Rad Laboratories, Inc.; BioMarin, Sarepta Therapeutics  among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Why Choose Us


Frequently Asked Questions